CANC
Tema Oncology ETF · NAS
- Category Equity
- Expense Ratio 0.75%
- Listing Date Aug 15, 2023
- Volume 235.0
- Market Cap (AUM) $18.51M
Performance
-1.24%
1W
+3.72%
1M
-0.41%
3M
+24.09%
6M
+3.14%
YTD
+9.22%
1Y
Top Holdings
-
Name
Symbol%Assets
- Merck & Co., Inc.MRK5.36%
- Regeneron Pharmaceuticals, Inc.REGN5.26%
- Daiichi Sankyo Company, Limited45684.18%
- AstraZeneca PLCAZN3.95%
- Novartis AGNOVN3.54%
- Illumina, Inc.ILMN3.46%
- Revolution Medicines, Inc.RVMD3.26%
- argenx SE ADRARGX2.92%
- Exact Sciences CorporationEXAS2.85%
- Blueprint Medicines Corp.BPMC2.66%
Technical Analysis of CANC 2024-05-10
Overview:
In analyzing the technical indicators for CANC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
Page 1 of 1
previousnext